Træk
Abdominal pain
An unpleasant sensation characterized by physical discomfort (such as pricking, throbbing, or aching) and perceived to originate in the abdomen.
Resumé
- Også kaldet
- Abdominal discomfort, Gastro pain, Gastrointestinal pain, Pain in stomach, Stomach pain, Upset stomach
Read the genes linked to Abdominal pain, and the rest of your genome, with one test.
Fra 449 $Gratis forsendelse · Resultater på 6–8 uger
Bestil min Genome Test327 gener knyttet til Abdominal pain
Ændringer i disse gener forårsager sjældne tilstande, hvor Abdominal pain ses. De fleste med dette træk har ingen af disse tilstande, og et gen på denne liste siger intet om nogens eget genom.
| Gen | Hvor ofte det ses | Tilstande |
|---|---|---|
| ABCB1ATP binding cassette subfamily B member 1 | Altid | I 1 tilstand |
| APRTadenine phosphoribosyltransferase | Altid | I 1 tilstand |
| CARD8caspase recruitment domain family member 8 | Altid | I 1 tilstand |
| CASKcalcium/calmodulin dependent serine protein kinase | Altid | I 1 tilstand |
| CEBPECCAAT enhancer binding protein epsilon | Altid | I 1 tilstand |
| FDXRferredoxin reductase | Altid | I 1 tilstand |
| G6PDglucose-6-phosphate dehydrogenase | Altid | I 1 tilstand |
| GUK1guanylate kinase 1 | Altid | I 1 tilstand |
| IRF4interferon regulatory factor 4 | Altid | I 2 tilstande |
| LYNLYN proto-oncogene, Src family tyrosine kinase | Altid | I 1 tilstand |
| NCF4neutrophil cytosolic factor 4 | Altid | I 1 tilstand |
| PIGTphosphatidylinositol glycan anchor biosynthesis class T | Altid | I 1 tilstand |
| PIGYphosphatidylinositol glycan anchor biosynthesis class Y | Altid | I 1 tilstand |
| PIK3CGphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | Altid | I 1 tilstand |
| PLD4phospholipase D family member 4 | Altid | I 1 tilstand |
| PPOXprotoporphyrinogen oxidase | Altid | I 2 tilstande |
| RAD21RAD21 cohesin complex component | Altid | I 1 tilstand |
| RNU6ATACRNA, U6atac small nuclear | Altid | I 1 tilstand |
| STK11serine/threonine kinase 11 | Altid | I 2 tilstande |
| TRU-TCA1-1tRNA-SeC (anticodon TCA) 1-1 | Altid | I 1 tilstand |
| ABCD1ATP binding cassette subfamily D member 1 | Meget ofte (80–99 %) | I 1 tilstand |
| ALDOBaldolase, fructose-bisphosphate B | Meget ofte (80–99 %) | I 2 tilstande |
| ATMATM serine/threonine kinase | Meget ofte (80–99 %) | I 1 tilstand |
| ATP7AATPase copper transporting alpha | Meget ofte (80–99 %) | I 1 tilstand |
| BAZ1Bbromodomain adjacent to zinc finger domain 1B | Meget ofte (80–99 %) | I 1 tilstand |
| BMPR1Abone morphogenetic protein receptor type 1A | Meget ofte (80–99 %) | I 3 tilstande |
| BRCA1BRCA1 DNA repair associated | Meget ofte (80–99 %) | I 3 tilstande |
| BRCA2BRCA2 DNA repair associated | Meget ofte (80–99 %) | I 4 tilstande |
| BUD23BUD23 rRNA methyltransferase and ribosome maturation factor | Meget ofte (80–99 %) | I 1 tilstand |
| CASRcalcium sensing receptor | Meget ofte (80–99 %) | I 2 tilstande |
| CD4CD4 molecule | Meget ofte (80–99 %) | I 1 tilstand |
| CDKN2Acyclin dependent kinase inhibitor 2A | Meget ofte (80–99 %) | I 2 tilstande |
| CHEK2checkpoint kinase 2 | Meget ofte (80–99 %) | I 1 tilstand |
| CLIP2CAP-Gly domain containing linker protein 2 | Meget ofte (80–99 %) | I 1 tilstand |
| CPA1carboxypeptidase A1 | Meget ofte (80–99 %) | I 1 tilstand |
| CPOXcoproporphyrinogen oxidase | Meget ofte (80–99 %) | I 2 tilstande |
| CTNNB1catenin beta 1 | Meget ofte (80–99 %) | I 3 tilstande |
| CTRCchymotrypsin C | Meget ofte (80–99 %) | I 2 tilstande |
| DNAJC30DnaJ heat shock protein family (Hsp40) member C30 | Meget ofte (80–99 %) | I 1 tilstand |
| ECE1endothelin converting enzyme 1 | Meget ofte (80–99 %) | I 1 tilstand |
Vis 287 gener mere
| Gen | Hvor ofte det ses | Tilstande |
|---|---|---|
| EDN3endothelin 3 | Meget ofte (80–99 %) | I 2 tilstande |
| EDNRBendothelin receptor type B | Meget ofte (80–99 %) | I 2 tilstande |
| EIF4Heukaryotic translation initiation factor 4H | Meget ofte (80–99 %) | I 1 tilstand |
| ELNelastin | Meget ofte (80–99 %) | I 1 tilstand |
| EPCAMepithelial cell adhesion molecule | Meget ofte (80–99 %) | I 1 tilstand |
| ERBB2erb-b2 receptor tyrosine kinase 2 | Meget ofte (80–99 %) | I 1 tilstand |
| ERBB3erb-b2 receptor tyrosine kinase 3 | Meget ofte (80–99 %) | I 1 tilstand |
| EWSR1EWS RNA binding protein 1 | Meget ofte (80–99 %) | I 1 tilstand |
| FKBP6FKBP prolyl isomerase family member 6 (inactive) | Meget ofte (80–99 %) | I 1 tilstand |
| FSHRfollicle stimulating hormone receptor | Meget ofte (80–99 %) | I 2 tilstande |
| GDNFglial cell derived neurotrophic factor | Meget ofte (80–99 %) | I 1 tilstand |
| GHSRgrowth hormone secretagogue receptor | Meget ofte (80–99 %) | I 1 tilstand |
| GLAgalactosidase alpha | Meget ofte (80–99 %) | I 2 tilstande |
| GTF2Igeneral transcription factor IIi | Meget ofte (80–99 %) | I 1 tilstand |
| GTF2IRD1GTF2I repeat domain containing 1 | Meget ofte (80–99 %) | I 1 tilstand |
| GTF2IRD2GTF2I repeat domain containing 2 | Meget ofte (80–99 %) | I 1 tilstand |
| HMBShydroxymethylbilane synthase | Meget ofte (80–99 %) | I 2 tilstande |
| JAK2Janus kinase 2 | Meget ofte (80–99 %) | I 2 tilstande |
| KRASKRas proto-oncogene, GTPase | Meget ofte (80–99 %) | I 2 tilstande |
| LIG3DNA ligase 3 | Meget ofte (80–99 %) | I 1 tilstand |
| LIMK1LIM domain kinase 1 | Meget ofte (80–99 %) | I 1 tilstand |
| MEFVMEFV innate immunity regulator, pyrin | Meget ofte (80–99 %) | I 4 tilstande |
| METMET proto-oncogene, receptor tyrosine kinase | Meget ofte (80–99 %) | I 1 tilstand |
| METTL27methyltransferase like 27 | Meget ofte (80–99 %) | I 1 tilstand |
| MLH1mutL homolog 1 | Meget ofte (80–99 %) | I 1 tilstand |
| MSH2mutS homolog 2 | Meget ofte (80–99 %) | I 1 tilstand |
| MSH6mutS homolog 6 | Meget ofte (80–99 %) | I 1 tilstand |
| MUTYHmutY DNA glycosylase | Meget ofte (80–99 %) | I 1 tilstand |
| MVKmevalonate kinase | Meget ofte (80–99 %) | I 2 tilstande |
| NCF1neutrophil cytosolic factor 1 | Meget ofte (80–99 %) | I 1 tilstand |
| NPATnuclear protein, coactivator of histone transcription | Meget ofte (80–99 %) | I 1 tilstand |
| NRTNneurturin | Meget ofte (80–99 %) | I 1 tilstand |
| PALB2partner and localizer of BRCA2 | Meget ofte (80–99 %) | I 1 tilstand |
| PALLDpalladin, cytoskeletal associated protein | Meget ofte (80–99 %) | I 1 tilstand |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Meget ofte (80–99 %) | I 1 tilstand |
| PMS1PMS1 homolog 1, mismatch repair system component | Meget ofte (80–99 %) | I 1 tilstand |
| PMS2PMS1 homolog 2, mismatch repair system component | Meget ofte (80–99 %) | I 1 tilstand |
| POLD1DNA polymerase delta 1, catalytic subunit | Meget ofte (80–99 %) | I 1 tilstand |
| POLEDNA polymerase epsilon, catalytic subunit | Meget ofte (80–99 %) | I 1 tilstand |
| POLGDNA polymerase gamma, catalytic subunit | Meget ofte (80–99 %) | I 3 tilstande |
| PRSS1serine protease 1 | Meget ofte (80–99 %) | I 2 tilstande |
| PRSS2serine protease 2 | Meget ofte (80–99 %) | I 2 tilstande |
| RABL3RAB, member of RAS oncogene family like 3 | Meget ofte (80–99 %) | I 1 tilstand |
| RETret proto-oncogene | Meget ofte (80–99 %) | I 1 tilstand |
| RFC2replication factor C subunit 2 | Meget ofte (80–99 %) | I 1 tilstand |
| RPS20ribosomal protein S20 | Meget ofte (80–99 %) | I 1 tilstand |
| RRM2Bribonucleotide reductase regulatory TP53 inducible subunit M2B | Meget ofte (80–99 %) | I 1 tilstand |
| SDHAsuccinate dehydrogenase complex flavoprotein subunit A | Meget ofte (80–99 %) | I 2 tilstande |
| SDHBsuccinate dehydrogenase complex iron sulfur subunit B | Meget ofte (80–99 %) | I 2 tilstande |
| SDHCsuccinate dehydrogenase complex subunit C | Meget ofte (80–99 %) | I 2 tilstande |
| SEMA3Csemaphorin 3C | Meget ofte (80–99 %) | I 1 tilstand |
| SEMA3Dsemaphorin 3D | Meget ofte (80–99 %) | I 1 tilstand |
| SEMA4Asemaphorin 4A | Meget ofte (80–99 %) | I 1 tilstand |
| SERPING1serpin family G member 1 | Meget ofte (80–99 %) | I 2 tilstande |
| SIsucrase-isomaltase | Meget ofte (80–99 %) | I 2 tilstande |
| SMAD4SMAD family member 4 | Meget ofte (80–99 %) | I 2 tilstande |
| SMOsmoothened, frizzled class receptor | Meget ofte (80–99 %) | I 1 tilstand |
| SOX10SRY-box transcription factor 10 | Meget ofte (80–99 %) | I 2 tilstande |
| SREBF1sterol regulatory element binding transcription factor 1 | Meget ofte (80–99 %) | I 1 tilstand |
| STX1Asyntaxin 1A | Meget ofte (80–99 %) | I 1 tilstand |
| TBL2transducin beta like 2 | Meget ofte (80–99 %) | I 1 tilstand |
| TGFBR2transforming growth factor beta receptor 2 | Meget ofte (80–99 %) | I 1 tilstand |
| TMEM270transmembrane protein 270 | Meget ofte (80–99 %) | I 1 tilstand |
| TNFRSF1ATNF receptor superfamily member 1A | Meget ofte (80–99 %) | I 2 tilstande |
| TP53tumor protein p53 | Meget ofte (80–99 %) | I 2 tilstande |
| TRPV6transient receptor potential cation channel subfamily V member 6 | Meget ofte (80–99 %) | I 1 tilstand |
| TYMPthymidine phosphorylase | Meget ofte (80–99 %) | I 2 tilstande |
| VPS37DVPS37D subunit of ESCRT-I | Meget ofte (80–99 %) | I 1 tilstand |
| WT1WT1 transcription factor | Meget ofte (80–99 %) | I 3 tilstande |
| ABCA1ATP binding cassette subfamily A member 1 | Ofte (30–79 %) | I 1 tilstand |
| ALADaminolevulinate dehydratase | Ofte (30–79 %) | I 1 tilstand |
| APCAPC regulator of Wnt signaling pathway | Ofte (30–79 %) | I 2 tilstande |
| ASXL1ASXL transcriptional regulator 1 | Ofte (30–79 %) | I 2 tilstande |
| BMP6bone morphogenetic protein 6 | Ofte (30–79 %) | I 1 tilstand |
| C4Acomplement C4A (Chido/Rodgers blood group) | Ofte (30–79 %) | I 1 tilstand |
| CALRcalreticulin | Ofte (30–79 %) | I 1 tilstand |
| CBLCbl proto-oncogene | Ofte (30–79 %) | I 1 tilstand |
| CCR1C-C motif chemokine receptor 1 | Ofte (30–79 %) | I 1 tilstand |
| CD55CD55 molecule (Cromer blood group) | Ofte (30–79 %) | I 1 tilstand |
| CDKN1Bcyclin dependent kinase inhibitor 1B | Ofte (30–79 %) | I 1 tilstand |
| CDKN2Bcyclin dependent kinase inhibitor 2B | Ofte (30–79 %) | I 1 tilstand |
| CLCNKBchloride voltage-gated channel Kb | Ofte (30–79 %) | I 1 tilstand |
| CLDN16claudin 16 | Ofte (30–79 %) | I 1 tilstand |
| CLPBClpB family mitochondrial disaggregase | Ofte (30–79 %) | I 1 tilstand |
| CNBPCCHC-type zinc finger nucleic acid binding protein | Ofte (30–79 %) | I 1 tilstand |
| CTLA4cytotoxic T-lymphocyte associated protein 4 | Ofte (30–79 %) | I 1 tilstand |
| CTR9CTR9 component of Paf1/RNA polymerase II complex | Ofte (30–79 %) | I 1 tilstand |
| DIS3L2DIS3 like 3'-5' exoribonuclease 2 | Ofte (30–79 %) | I 1 tilstand |
| DNASE1L3deoxyribonuclease 1L3 | Ofte (30–79 %) | I 1 tilstand |
| ELANEelastase, neutrophil expressed | Ofte (30–79 %) | I 2 tilstande |
| ELF4E74 like ETS transcription factor 4 | Ofte (30–79 %) | I 1 tilstand |
| EPORerythropoietin receptor | Ofte (30–79 %) | I 1 tilstand |
| ERAP1endoplasmic reticulum aminopeptidase 1 | Ofte (30–79 %) | I 1 tilstand |
| F5coagulation factor V | Ofte (30–79 %) | I 1 tilstand |
| FASFas cell surface death receptor | Ofte (30–79 %) | I 1 tilstand |
| GBA1glucosylceramidase beta 1 | Ofte (30–79 %) | I 1 tilstand |
| GCGRglucagon receptor | Ofte (30–79 %) | I 2 tilstande |
| GFI1growth factor independent 1 transcriptional repressor | Ofte (30–79 %) | I 1 tilstand |
| GNA11G protein subunit alpha 11 | Ofte (30–79 %) | I 1 tilstand |
| GOSR2golgi SNAP receptor complex member 2 | Ofte (30–79 %) | I 1 tilstand |
| GPC3glypican 3 | Ofte (30–79 %) | I 1 tilstand |
| H19H19 imprinted maternally expressed transcript | Ofte (30–79 %) | I 1 tilstand |
| HFEhomeostatic iron regulator | Ofte (30–79 %) | I 2 tilstande |
| HLA-Bmajor histocompatibility complex, class I, B | Ofte (30–79 %) | I 4 tilstande |
| HLA-DPA1major histocompatibility complex, class II, DP alpha 1 | Ofte (30–79 %) | I 1 tilstand |
| HLA-DPB1major histocompatibility complex, class II, DP beta 1 | Ofte (30–79 %) | I 1 tilstand |
| IFNGR1interferon gamma receptor 1 | Ofte (30–79 %) | I 1 tilstand |
| IL10interleukin 10 | Ofte (30–79 %) | I 1 tilstand |
| IL12Ainterleukin 12A | Ofte (30–79 %) | I 1 tilstand |
| IL12A-AS1IL12A antisense RNA 1 | Ofte (30–79 %) | I 1 tilstand |
| IL23Rinterleukin 23 receptor | Ofte (30–79 %) | I 1 tilstand |
| KLRC4killer cell lectin like receptor C4 | Ofte (30–79 %) | I 1 tilstand |
| MED12mediator complex subunit 12 | Ofte (30–79 %) | I 1 tilstand |
| MEN1menin 1 | Ofte (30–79 %) | I 1 tilstand |
| MITFmelanocyte inducing transcription factor | Ofte (30–79 %) | I 1 tilstand |
| NKX2-5NK2 homeobox 5 | Ofte (30–79 %) | I 1 tilstand |
| NLRP3NLR family pyrin domain containing 3 | Ofte (30–79 %) | I 2 tilstande |
| NOD2nucleotide binding oligomerization domain containing 2 | Ofte (30–79 %) | I 2 tilstande |
| OTULINOTU deubiquitinase with linear linkage specificity | Ofte (30–79 %) | I 1 tilstand |
| PKHD1PKHD1 ciliary IPT domain containing fibrocystin/polyductin | Ofte (30–79 %) | I 1 tilstand |
| POU6F2POU class 6 homeobox 2 | Ofte (30–79 %) | I 1 tilstand |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Ofte (30–79 %) | I 2 tilstande |
| PRTN3proteinase 3 | Ofte (30–79 %) | I 1 tilstand |
| PTENphosphatase and tensin homolog | Ofte (30–79 %) | I 1 tilstand |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Ofte (30–79 %) | I 2 tilstande |
| RBCK1RANBP2-type and C3HC4-type zinc finger containing 1 | Ofte (30–79 %) | I 1 tilstand |
| RESTRE1 silencing transcription factor | Ofte (30–79 %) | I 1 tilstand |
| RIPK1receptor interacting serine/threonine kinase 1 | Ofte (30–79 %) | I 1 tilstand |
| RUNX1RUNX family transcription factor 1 | Ofte (30–79 %) | I 1 tilstand |
| SAA1serum amyloid A1 | Ofte (30–79 %) | I 1 tilstand |
| SCARB2scavenger receptor class B member 2 | Ofte (30–79 %) | I 1 tilstand |
| SCN1Bsodium voltage-gated channel beta subunit 1 | Ofte (30–79 %) | I 1 tilstand |
| SCN5Asodium voltage-gated channel alpha subunit 5 | Ofte (30–79 %) | I 1 tilstand |
| SDHDsuccinate dehydrogenase complex subunit D | Ofte (30–79 %) | I 1 tilstand |
| SLC12A3solute carrier family 12 member 3 | Ofte (30–79 %) | I 2 tilstande |
| SRP19signal recognition particle 19 | Ofte (30–79 %) | I 1 tilstand |
| SRSF2serine and arginine rich splicing factor 2 | Ofte (30–79 %) | I 2 tilstande |
| STAT4signal transducer and activator of transcription 4 | Ofte (30–79 %) | I 2 tilstande |
| TCIRG1T cell immune regulator 1, ATPase H+ transporting V0 subunit a3 | Ofte (30–79 %) | I 1 tilstand |
| TERTtelomerase reverse transcriptase | Ofte (30–79 %) | I 1 tilstand |
| TET2tet methylcytosine dioxygenase 2 | Ofte (30–79 %) | I 2 tilstande |
| TLR4toll like receptor 4 | Ofte (30–79 %) | I 1 tilstand |
| TRIM28tripartite motif containing 28 | Ofte (30–79 %) | I 1 tilstand |
| TRIP13thyroid hormone receptor interactor 13 | Ofte (30–79 %) | I 1 tilstand |
| TRPM4transient receptor potential cation channel subfamily M member 4 | Ofte (30–79 %) | I 1 tilstand |
| TSC1TSC complex subunit 1 | Ofte (30–79 %) | I 1 tilstand |
| TSC2TSC complex subunit 2 | Ofte (30–79 %) | I 1 tilstand |
| UBAC2UBA domain containing 2 | Ofte (30–79 %) | I 1 tilstand |
| UQCRHubiquinol-cytochrome c reductase hinge protein | Ofte (30–79 %) | I 1 tilstand |
| ZNRF3zinc and ring finger 3 | Ofte (30–79 %) | I 1 tilstand |
| ABCC2ATP binding cassette subfamily C member 2 | Nogle gange (5–29 %) | I 1 tilstand |
| ACTN4actinin alpha 4 | Nogle gange (5–29 %) | I 1 tilstand |
| ALDH4A1aldehyde dehydrogenase 4 family member A1 | Nogle gange (5–29 %) | I 1 tilstand |
| ALG8ALG8 alpha-1,3-glucosyltransferase | Nogle gange (5–29 %) | I 1 tilstand |
| ANK1ankyrin 1 | Nogle gange (5–29 %) | I 1 tilstand |
| ANKFY1ankyrin repeat and FYVE domain containing 1 | Nogle gange (5–29 %) | I 1 tilstand |
| ANLNanillin, actin binding protein | Nogle gange (5–29 %) | I 1 tilstand |
| APOL1apolipoprotein L1 | Nogle gange (5–29 %) | I 1 tilstand |
| ARHGAP24Rho GTPase activating protein 24 | Nogle gange (5–29 %) | I 1 tilstand |
| ARHGDIARho GDP dissociation inhibitor alpha | Nogle gange (5–29 %) | I 1 tilstand |
| ATP7BATPase copper transporting beta | Nogle gange (5–29 %) | I 1 tilstand |
| AVILadvillin | Nogle gange (5–29 %) | I 1 tilstand |
| BCL10BCL10 immune signaling adaptor | Nogle gange (5–29 %) | I 1 tilstand |
| BCL11ABCL11 transcription factor A | Nogle gange (5–29 %) | I 1 tilstand |
| BCORBCL6 corepressor | Nogle gange (5–29 %) | I 1 tilstand |
| BIRC3baculoviral IAP repeat containing 3 | Nogle gange (5–29 %) | I 1 tilstand |
| BNC2basonuclin zinc finger protein 2 | Nogle gange (5–29 %) | I 1 tilstand |
| CCND1cyclin D1 | Nogle gange (5–29 %) | I 1 tilstand |
| CD2APCD2 associated protein | Nogle gange (5–29 %) | I 1 tilstand |
| CD46CD46 molecule | Nogle gange (5–29 %) | I 1 tilstand |
| CFHcomplement factor H | Nogle gange (5–29 %) | I 1 tilstand |
| CFIcomplement factor I | Nogle gange (5–29 %) | I 1 tilstand |
| COL4A3collagen type IV alpha 3 chain | Nogle gange (5–29 %) | I 1 tilstand |
| COQ8Bcoenzyme Q8B | Nogle gange (5–29 %) | I 1 tilstand |
| CORINcorin, serine peptidase | Nogle gange (5–29 %) | I 1 tilstand |
| CRB2crumbs cell polarity complex component 2 | Nogle gange (5–29 %) | I 1 tilstand |
| DAAM2dishevelled associated activator of morphogenesis 2 | Nogle gange (5–29 %) | I 1 tilstand |
| DDIT3DNA damage inducible transcript 3 | Nogle gange (5–29 %) | I 1 tilstand |
| DMPKDM1 protein kinase | Nogle gange (5–29 %) | I 1 tilstand |
| EMP2epithelial membrane protein 2 | Nogle gange (5–29 %) | I 1 tilstand |
| EPB42erythrocyte membrane protein band 4.2 | Nogle gange (5–29 %) | I 1 tilstand |
| FGF13fibroblast growth factor 13 | Nogle gange (5–29 %) | I 1 tilstand |
| FIP1L1factor interacting with PAPOLA and CPSF1 | Nogle gange (5–29 %) | I 1 tilstand |
| FLT1fms related receptor tyrosine kinase 1 | Nogle gange (5–29 %) | I 1 tilstand |
| FOXP1forkhead box P1 | Nogle gange (5–29 %) | I 1 tilstand |
| FUSFUS RNA binding protein | Nogle gange (5–29 %) | I 1 tilstand |
| GAPVD1GTPase activating protein and VPS9 domains 1 | Nogle gange (5–29 %) | I 1 tilstand |
| GPR35G protein-coupled receptor 35 | Nogle gange (5–29 %) | I 1 tilstand |
| HBBhemoglobin subunit beta | Nogle gange (5–29 %) | I 3 tilstande |
| HBG1hemoglobin subunit gamma 1 | Nogle gange (5–29 %) | I 1 tilstand |
| HBG2hemoglobin subunit gamma 2 | Nogle gange (5–29 %) | I 1 tilstand |
| HELLPARHELLP associated long non-coding RNA | Nogle gange (5–29 %) | I 1 tilstand |
| HIVEP2HIVEP zinc finger 2 | Nogle gange (5–29 %) | I 1 tilstand |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Nogle gange (5–29 %) | I 2 tilstande |
| IGHimmunoglobulin heavy locus | Nogle gange (5–29 %) | I 1 tilstand |
| IKZF1IKAROS family zinc finger 1 | Nogle gange (5–29 %) | I 1 tilstand |
| IL6interleukin 6 | Nogle gange (5–29 %) | I 2 tilstande |
| INF2inverted formin 2 | Nogle gange (5–29 %) | I 1 tilstand |
| IRAK1interleukin 1 receptor associated kinase 1 | Nogle gange (5–29 %) | I 1 tilstand |
| IRF2BP2interferon regulatory factor 2 binding protein 2 | Nogle gange (5–29 %) | I 1 tilstand |
| KANK2KN motif and ankyrin repeat domains 2 | Nogle gange (5–29 %) | I 1 tilstand |
| KCNN4potassium calcium-activated channel subfamily N member 4 | Nogle gange (5–29 %) | I 1 tilstand |
| KITKIT proto-oncogene, receptor tyrosine kinase | Nogle gange (5–29 %) | I 2 tilstande |
| KLF1KLF transcription factor 1 | Nogle gange (5–29 %) | I 1 tilstand |
| LACC1laccase domain multifunctional purine nucleosidase 1 | Nogle gange (5–29 %) | I 1 tilstand |
| LAMA5laminin subunit alpha 5 | Nogle gange (5–29 %) | I 1 tilstand |
| LRP5LDL receptor related protein 5 | Nogle gange (5–29 %) | I 1 tilstand |
| MAGI2membrane associated guanylate kinase, WW and PDZ domain containing 2 | Nogle gange (5–29 %) | I 1 tilstand |
| MALT1MALT1 paracaspase | Nogle gange (5–29 %) | I 1 tilstand |
| MIFmacrophage migration inhibitory factor | Nogle gange (5–29 %) | I 1 tilstand |
| MMUTmethylmalonyl-CoA mutase | Nogle gange (5–29 %) | I 1 tilstand |
| MST1macrophage stimulating 1 | Nogle gange (5–29 %) | I 1 tilstand |
| MYCMYC proto-oncogene, bHLH transcription factor | Nogle gange (5–29 %) | I 1 tilstand |
| MYO1Emyosin IE | Nogle gange (5–29 %) | I 1 tilstand |
| NABP1nucleic acid binding protein 1 | Nogle gange (5–29 %) | I 1 tilstand |
| NPHS1NPHS1 adhesion molecule, nephrin | Nogle gange (5–29 %) | I 1 tilstand |
| NPHS2NPHS2 stomatin family member, podocin | Nogle gange (5–29 %) | I 1 tilstand |
| NPM1nucleophosmin 1 | Nogle gange (5–29 %) | I 1 tilstand |
| NUMA1nuclear mitotic apparatus protein 1 | Nogle gange (5–29 %) | I 1 tilstand |
| NUP107nucleoporin 107 | Nogle gange (5–29 %) | I 1 tilstand |
| NUP133nucleoporin 133 | Nogle gange (5–29 %) | I 1 tilstand |
| NUP160nucleoporin 160 | Nogle gange (5–29 %) | I 1 tilstand |
| NUP205nucleoporin 205 | Nogle gange (5–29 %) | I 1 tilstand |
| NUP37nucleoporin 37 | Nogle gange (5–29 %) | I 1 tilstand |
| NUP85nucleoporin 85 | Nogle gange (5–29 %) | I 1 tilstand |
| NUP93nucleoporin 93 | Nogle gange (5–29 %) | I 1 tilstand |
| OTCornithine transcarbamylase | Nogle gange (5–29 %) | I 1 tilstand |
| P4HA2prolyl 4-hydroxylase subunit alpha 2 | Nogle gange (5–29 %) | I 1 tilstand |
| PAX2paired box 2 | Nogle gange (5–29 %) | I 1 tilstand |
| PIEZO1piezo type mechanosensitive ion channel component 1 (Er blood group) | Nogle gange (5–29 %) | I 1 tilstand |
| PLCE1phospholipase C epsilon 1 | Nogle gange (5–29 %) | I 1 tilstand |
| PMLPML nuclear body scaffold | Nogle gange (5–29 %) | I 1 tilstand |
| POMT1protein O-mannosyltransferase 1 | Nogle gange (5–29 %) | I 1 tilstand |
| PORCNporcupine O-acyltransferase | Nogle gange (5–29 %) | I 1 tilstand |
| PRKCSHPRKCSH beta subunit of glucosidase II | Nogle gange (5–29 %) | I 1 tilstand |
| PTPN3protein tyrosine phosphatase non-receptor type 3 | Nogle gange (5–29 %) | I 1 tilstand |
| PTPROprotein tyrosine phosphatase receptor type O | Nogle gange (5–29 %) | I 1 tilstand |
| RARAretinoic acid receptor alpha | Nogle gange (5–29 %) | I 1 tilstand |
| RNF168ring finger protein 168 | Nogle gange (5–29 %) | I 1 tilstand |
| ROS1ROS proto-oncogene 1, receptor tyrosine kinase | Nogle gange (5–29 %) | I 1 tilstand |
| SAT1spermidine/spermine N1-acetyltransferase 1 | Nogle gange (5–29 %) | I 1 tilstand |
| SEC63SEC63 protein translocation regulator | Nogle gange (5–29 %) | I 1 tilstand |
| SEMA4Dsemaphorin 4D | Nogle gange (5–29 %) | I 1 tilstand |
| SLC4A1solute carrier family 4 member 1 (Diego blood group) | Nogle gange (5–29 %) | I 2 tilstande |
| SMPD1sphingomyelin phosphodiesterase 1 | Nogle gange (5–29 %) | I 1 tilstand |
| SPP1secreted phosphoprotein 1 | Nogle gange (5–29 %) | I 1 tilstand |
| SPTA1spectrin alpha, erythrocytic 1 | Nogle gange (5–29 %) | I 2 tilstande |
| SPTBspectrin beta, erythrocytic | Nogle gange (5–29 %) | I 2 tilstande |
| STAT3signal transducer and activator of transcription 3 | Nogle gange (5–29 %) | I 2 tilstande |
| STAT5Bsignal transducer and activator of transcription 5B | Nogle gange (5–29 %) | I 1 tilstand |
| STOX1storkhead box 1 | Nogle gange (5–29 %) | I 1 tilstand |
| SYKspleen associated tyrosine kinase | Nogle gange (5–29 %) | I 1 tilstand |
| TBC1D8BTBC1 domain family member 8B | Nogle gange (5–29 %) | I 1 tilstand |
| TBK1TANK binding kinase 1 | Nogle gange (5–29 %) | I 1 tilstand |
| TBL1XR1TBL1X/Y related 1 | Nogle gange (5–29 %) | I 1 tilstand |
| TCF4transcription factor 4 | Nogle gange (5–29 %) | I 1 tilstand |
| TFR2transferrin receptor 2 | Nogle gange (5–29 %) | I 1 tilstand |
| TREHtrehalase | Nogle gange (5–29 %) | I 2 tilstande |
| TRPC6transient receptor potential cation channel subfamily C member 6 | Nogle gange (5–29 %) | I 1 tilstand |
| UNC45Aunc-45 myosin chaperone A | Nogle gange (5–29 %) | I 1 tilstand |
| VHLvon Hippel-Lindau tumor suppressor | Nogle gange (5–29 %) | I 1 tilstand |
| ZBTB16zinc finger and BTB domain containing 16 | Nogle gange (5–29 %) | I 1 tilstand |
| ABCB11ATP binding cassette subfamily B member 11 | Sjældent (1–4%) | I 1 tilstand |
| ABCB4ATP binding cassette subfamily B member 4 | Sjældent (1–4%) | I 1 tilstand |
| ATP8B1ATPase phospholipid transporting 8B1 | Sjældent (1–4%) | I 1 tilstand |
| EPB41erythrocyte membrane protein band 4.1 | Sjældent (1–4%) | I 1 tilstand |
| GYPCglycophorin C (Gerbich blood group) | Sjældent (1–4%) | I 1 tilstand |
| NR1H4nuclear receptor subfamily 1 group H member 4 | Sjældent (1–4%) | I 1 tilstand |
| SPTBN1spectrin beta, non-erythrocytic 1 | Sjældent (1–4%) | I 1 tilstand |
| ABCG8ATP binding cassette subfamily G member 8 | Ikke registreret | I 1 tilstand |
| ACTG2actin gamma 2, smooth muscle | Ikke registreret | I 1 tilstand |
| ADA2adenosine deaminase 2 | Ikke registreret | I 1 tilstand |
| BMP2bone morphogenetic protein 2 | Ikke registreret | I 1 tilstand |
| CELcarboxyl ester lipase | Ikke registreret | I 1 tilstand |
| CFTRCF transmembrane conductance regulator | Ikke registreret | I 1 tilstand |
| GUCY2Cguanylate cyclase 2C | Ikke registreret | I 1 tilstand |
| HLA-DQA1major histocompatibility complex, class II, DQ alpha 1 | Ikke registreret | I 1 tilstand |
| HLA-DQB1major histocompatibility complex, class II, DQ beta 1 | Ikke registreret | I 1 tilstand |
| HPS1HPS1 biogenesis of lysosomal organelles complex 3 subunit 1 | Ikke registreret | I 1 tilstand |
| HS3ST6heparan sulfate-glucosamine 3-sulfotransferase 6 | Ikke registreret | I 1 tilstand |
| KIF1Bkinesin family member 1B | Ikke registreret | I 1 tilstand |
| MCM6minichromosome maintenance complex component 6 | Ikke registreret | I 1 tilstand |
| MLYCDmalonyl-CoA decarboxylase | Ikke registreret | I 1 tilstand |
| NLRP12NLR family pyrin domain containing 12 | Ikke registreret | I 1 tilstand |
| OPLAH5-oxoprolinase, ATP-hydrolysing | Ikke registreret | I 1 tilstand |
| SLC25A26solute carrier family 25 member 26 | Ikke registreret | I 1 tilstand |
| SPINK1serine peptidase inhibitor Kazal type 1 | Ikke registreret | I 2 tilstande |
Hvor hyppigt det ses hos personer med en af genets tilstande, den hyppigste værdi på tværs af dem, sådan som Human Phenotype Ontology registrerer det. Disse sider beskriver egenskaber og den forskning, der ligger bag dem. De er ikke en diagnose, og hvis du har spørgsmål om symptomer, bør du spørge en læge eller genetisk rådgiver.
Snævrere træk
Bredere træk
Hvor oplysningerne kommer fra
- Human Phenotype Ontology, udgivelse 2026-09-01: egenskaben, dens navne, definition og de gener, der er knyttet til den. Læs mere på hpo.jax.org.
- Dataudgivelse 2026.10.16-c6eea6bf.
Én test. Svar for hele livet.
Fra 449 $Gratis forsendelse · Resultater på 6–8 uger